Global Health

ASSOCIATED PRESS  By MICHELLE FAUL and JAMEY KEATEN Nov. 27, 2014

CONAKRY, Guinea --   ...President Alpha Conde says his government must coordinate the  (expected French)  response, one that aid workers say is confusing and inefficient. Overall the responsibility for the crisis has changed hands several times, from WHO’s regional Africa office, to its headquarters and finally to the U.N. mission.

“It’s difficult for us to understand who is working for (which) WHO” - the local Africa division or the central office in Geneva, said Pascal Piguet, a logistics expert with Doctors Without Borders who leads the Ebola treatment center in the southern town of Gueckedou....

Oyewale Tomori, a professor of virology at Redeemer’s University in Nigeria who sits on WHO’s emergency committee on Ebola, said countries themselves should be coordinating the Ebola control efforts with help from agencies like the U.S. CDC and WHO. “But that’s not happening. We have a very fractured response,” Tomori added....

NEW YORK TIMES   By Jeffrey Gettleman                        Nov.28, 2014

KISSI TOWN, Sierra Leone-- ...While health officials say they are making headway against the Ebola epidemic in neighboring Liberia, the disease is still raging in Sierra Leone, despite the big international push. In November alone, the World Health Organization has reported more than 1,800 new cases in this country, about three times as many as in Liberia, which until recently had been the center of the outbreak....

On Freetown’s outskirts, burly youth are setting up roadblocks. The police are nowhere to be found. The young men barricade the road brandishing digital thermometers. Credit Daniel Berehulak for The New York Times

CNN -- By Laura Smith-Spark                              Nov. 27, 2014

The first human trial of an experimental Ebola vaccine has produced promising results, U.S. scientists said, raising hopes that protection from the deadly disease may be on the horizon.

All 20 healthy adults who received the vaccine in a trial run by researchers from the National Institutes of Health in Maryland produced an immune response and developed anti-Ebola antibodies, the NIH said Wednesday.

None suffered serious side effects, although two people developed a brief fever within a day of vaccination.

The vaccine is being developed by the NIH's National Institute of Allergy and Infectious Diseases and British pharmaceutical giant GlaxoSmithKline. The process has been fast-tracked in light of the current catastrophic Ebola outbreak in West Africa, which has claimed more than 5,000 lives.

http://www.cnn.com/2014/11/27/health/ebola-outbreak/

Health workers spray themselves with chlorine disinfectants after removing the body a woman who died of Ebola virus in the Aberdeen district of Freetown, Sierra Leone, October 14, 2014.  Credit: Reuters/Josephus Olu-Mammah

reuters.com - by Emma Farge - November 26, 2014

(Reuters) - Sierra Leone appealed to the United States on Wednesday to send military aid to help it battle Ebola as it falls behind its West African neighbors Guinea and Liberia in the fight against the virus.

The worst recorded Ebola outbreak has killed at least 5,689 people, the World Health Organization said on Wednesday, as the virus has overwhelmed African countries with weak infrastructure and healthcare systemS.

(READ COMPLETE ARTICLE)